104 related articles for article (PubMed ID: 3787569)
1. The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
Small M; Lowe GD; MacCuish AC; Forbes CD
Thromb Res; 1986 Oct; 44(2):253-9. PubMed ID: 3787569
[No Abstract] [Full Text] [Related]
2. Treatment with stanozolol before thrombolysis in patients with arterial occlusions.
Noll G; Lämmle B; Duckert F
Thromb Res; 1985 Feb; 37(4):529-32. PubMed ID: 3983908
[TBL] [Abstract][Full Text] [Related]
3. Oral stanozolol: effects on plasma and saliva fibrinolysis and plasma viscosity in normal males.
Small M; McArdle BM; Lowe GD; Brodie MJ; Forbes CD; Prentice CR
Thromb Res; 1983 Jul; 31(2):233-7. PubMed ID: 6685353
[No Abstract] [Full Text] [Related]
4. Haemostatic effects of stanozolol in elderly medical patients.
Small M; MacLean JA; McArdle BM; Bertina RM; Lowe GD; Forbes CD
Thromb Res; 1984 Aug; 35(3):353-8. PubMed ID: 6547787
[No Abstract] [Full Text] [Related]
5. The fibrinolytic response to stanozolol in normal subjects.
Preston FE; Burakowski BK; Porter NR; Malia RG
Thromb Res; 1981 Jun 1-25; 22(5-6):543-51. PubMed ID: 6171045
[No Abstract] [Full Text] [Related]
6. Fibrinolytic enhancement by stanozolol: a double blind trial.
Davidson JF; Lochhead M; McDonald GA; McNicol GP
Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
[No Abstract] [Full Text] [Related]
7. Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol.
Chakrabarti R; Fearnley GR; Evans JF
Lancet; 1970 Mar; 1(7647):591-3. PubMed ID: 4190544
[No Abstract] [Full Text] [Related]
8. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
Bielawiec M; Myśliwiec M; Perzanowski A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
[No Abstract] [Full Text] [Related]
9. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
Brochier M; Griguer P
Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
[No Abstract] [Full Text] [Related]
10. Treatment of hereditary protein C deficiency with stanozolol.
Broekmans AW; Conard J; van Weyenberg RG; Horellou MH; Kluft C; Bertina RM
Thromb Haemost; 1987 Feb; 57(1):20-4. PubMed ID: 3590078
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin and the fibrinolytic system in ischemic vascular disease.
Szczeklik A; Kopec M; Sladek K; Musial J; Chmielewska J; Teisseyre E; Dudek-Wojciechowska G; Palester-Chlebowczyk M
Thromb Res; 1983 Mar; 29(6):655-60. PubMed ID: 6344316
[No Abstract] [Full Text] [Related]
15. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
17. Severity of coronary artery disease and basal fibrinolysis.
Small M; Lowe GD; Beattie JM; Hutton I; Lorimer AR; Forbes CD
Haemostasis; 1987; 17(5):305-11. PubMed ID: 2444504
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation.
Prowse CV; Dawes J; Lane DA; Ireland H; Knight I
Thromb Res; 1982 Jul; 27(1):91-7. PubMed ID: 6750837
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma fibrinolysis in patients with rheumatoid arthritis.
Belch JJ; McArdle B; Madhok R; McLaughlin K; Capell HA; Forbes CD; Sturrock RD
Ann Rheum Dis; 1984 Dec; 43(6):774-7. PubMed ID: 6084477
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
Chakrabarti R
Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
